The human papilloma virus (HPV) is the most common viral infection of the genital system.
HPV is an extremely widespread group of viruses in the world. This virus has more than 190 of them, leads to the development of at least 13 cancers (known as high risk). The Papilloma virus is mainly transmitted due to sexual ties, and most people have infected them shortly after sex. HPV (16 and 18) is caused by 70% of the two types of cervical cancer (RSHM) and cereal psychological situations.
The Papilloma virus is mainly transmitted due to sexual ties, and most people have infected them shortly after sex. However, no penetrating sex is required to transfer the virus. The connection in the abdomen is a good transmission of the transmission of the Papillomavirus infection. The risk groups of HPV infection are children and adolescents aged 15-18.
Cervical cancer, certain types are developing as a result of sexual infection related to HPV. Risk factors for the development of RSC: first sex at the beginning of an early age; A large number of sexual partners; Immunity suppression (eg HIV-infected people are exposed to the risk of HPV infection and are infected with a wider range of VPV types).
Most HPV infections do not cause symptoms or diseases, and do not pass themselves (about 90% pass within 2 years). However, a fixed infection with certain types of HPV (with the most 16 and 18 types), the forecast can cause the development of pathological conditions. Without treatment, these conditions can turn into cervical cancer. Today, the cervical cancer is the most common disease associated with Papilloma virus. Cervical cancer is the fourth of the most common types of cancer in women and the fourth of the seventh in general.
RSM symptoms usually appear in the advanced stage of cancer and can cover the following:
- Irregular, intermanstru (between menstruation) or pathological vaginal bleeding after sex;
- In back pain, legs or pelvis;
- Fatigue, weight loss, loss of appetite;
- Discharge of unpleasant feelings or an unpleasant odor in the vagina;
- A swollen foot.
In the next stages, more severe symptoms may appear.
Papillomavirus infection, anus, orofarynx, vulva, vagina and penis are 20-90% of the aircraft cell cancer. According to estimates, about 90% of all anal cancer HPV-16 and HPV-18, mainly of vulva cancer in older women, are related to HPV-16.
Due to low-risk types, HPV infection leads to anogental warts in men and women (tip condoud or sexually transmitted warts). The development of a sudden time and sexually transmitted warning between HPV-6 or 11 types is 11-12 months and is 5-6 months in young women. It is difficult to treat anogenitalized caprels.
HPV-6 and HPV-11 are a rare situation known as repeated respiratory papillomatosis (RRP), which occurs in other parts of respiratory tract or respiratory tract. The RRP is mainly observed in children under 5 years of age (minor PRP) or in the third life (adult RRP). In rare cases, the women with a sexual infection can deliver the virus to baby during birth. Absurd RRP can lead to a serious problem due to the congestion of respiratory tract.
It was described that in 100% of RSM is related to the oncogenic reason, such as Papilloma virus (HPV) types. In women with a normal immune system, cervical cancer is developing in 15-20 years. In women with a weakened immune system, for example, in the absence of a HIV infection, its development may take only 5-10 years. Different from cervical cancer, AngeleIster shows the number of relevant information about Cancer, the number of relevant information, human papillomavi's relationship with anus, vulva, vagina and penis. Although these types of cancer are less common than Rshm, the link with HPV is able to prevent them from using the same initial prevention strategies as cervical cancer.
HPV (especially 6 and 11 types) can cause cancer (especially 6 and 11) (a disease from the lungs and mouths on inflation roads on inflation roads on inflation roads). Although these conditions are very rare, it can often lead to a disease. Acute coffers are widespread and extremely infectious.
High global death from cervical cancer (52%), the reason is the human papillomaviru. In 2012, about 270 women died of RSM, and more than 85% of these deaths occurred in low and medium-income countries.
RSM options are tested for processor conditions and cancer among women who do not have symptoms and feel completely healthy. If the prosecutor's office reveals pathological conditions, it can be easily treated and thus prevents cancer. Screening can also determine in an early stage in which cancer is likely to be treated in an early stage.
Given that the prerequisites have developed for years, each woman aged 30-49 is highly recommended to look at least once in life and better. Death of the cervical cancer of the air is effective only to reduce the situation in a large number of women.
There are currently 3 different types of options:
- Ordinary papanicolau test (PAP) and liquid cytology (LBC);
- Visual inspection using acetic acid;
- HPV tests on high-risk types.
In developed countries, there are programs that allow women to identify the most applied conditions in the stages where women can be treated easily. Early treatment from the Papilloma virus allows you to avoid 80% of RSM development in these countries.
In developing countries, limited access to effective examination, the disease often means reveal during the recent stages and the development of symptoms. In addition, the treatment of the disease is ineffective in such stages, which leads to a high level of death from RSM in these countries.
The results of clinical trial show that the two existing vaccines today are safe and very effective in preventing the HPV infection 16 and 18. Therefore, the first sex is preferred to be vaccinated. Vaccines do not treat HPV infections or diseases associated with HPV (cancer).
In some countries, one of the most affected vaccines in men and women in both men and women in both men and women prevent genital warts in men and women. In addition, the boys' vaccine serves to prevent HPV turnover in teenagers and young adults. Who recommends the vaccine between the ages of 9-13, because it is the most effective in terms of expenses, in terms of public health.
Vaccination against HPV does not replace the examination of cervical cancer. VPV vaccine may also be necessary to develop selection programs in power. In the end of 2013, the Papilloma virus was introduced in 55 countries in the country.
In the coverage of modern mathematical modern girls, a vaccine against a vaccine against the papillomavirus infection, 63% of cervical intaepitelial neoplasy (forerun), can be predicted of cythological violations, cervical intraepitelial neoplasia risks. 30 years - 27%.
Currently, there are two vaccinations that protect the 16 and 18 types of people, which make up at least 70% of cervical cancer. These vaccines can also provide some cross-protection against other types of less common HPV, which lead to RSM. One of these vaccinations also leads to HPV 6 and 11 species, henry.
The development and registration of vaccines against the Papillomavirus infection determined the possibility of the initial prevention of the RSC.
Cervical cancer is the second most common type of cancer among women - calculations, 530 each year, a new disease event is recorded, about 270 people die.
Maintains growth trend on the road.
During the life, the probability of every woman's CRM disease is 0, 53%.
In the middle of the twentieth century, the scientist Harold Hausen found that women suffering from cervical cancer were constantly infected with the people. In 1983, Papillomavirus discovered DNA in a cervical cancer biopsy, and this incident can be considered the opening of the oncogen VPH-16 virus. In 2008, the Nobel Committee was awarded the Nobel Prize in Harald Zur Harald Zur Hausen to discover that the Papilloma virus could lead to cervical cancer.